Evidence map›Paper›PMID 41358199›Full record

ArticleFrontiers in molecular biosciences2025

Multi-omics integration analysis based on plasma circulating proteins reveals potential therapeutic targets for ulcerative colitis.

Jihai Zhou, Wenwen Zhao, Yiping Lin, Bo Yang, Dongjie Sun, Zhu Liu

Abstract read
In one paragraph

Article in Frontiers in molecular biosciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jihai Zhou *Department of Gastroenterology, Shandong Provincial Maternal and Child Health Care Hospital Affiliated to Qingdao University, Jinan, China.
Wenwen Zhao *Department of Gastroenterology, Shandong Provincial Maternal and Child Health Care Hospital Affiliated to Qingdao University, Jinan, China.
Yiping Lin *Department of Health Medicine, 900th Hospital of PLA Joint Logistic Support Force, Fuzong Clinical Medical College of Fujian Medical University, Fuzhou, China.
Bo YangDepartment of Gastroenterology and Hepatology, Guizhou Aerospace Hospital, Zunyi, China.
Dongjie Sun *Department of Digestive Diseases, 900th Hospital of PLA Joint Logistic Support Force, Fuzong Clinical Medical College of Fujian Medical University, Fuzhou, China.
Zhu Liu *Department of Gastroenterology, Shandong Provincial Maternal and Child Health Care Hospital Affiliated to Qingdao University, Jinan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Ulcerative colitis (UC) is a complex inflammatory bowel disease with unclear etiology and challenging molecular mechanisms. This study aims to identify potential diagnostic and therapeutic biomarkers for UC through multi-omics integrative analysis, providing new insights into its precise diagnosis and treatment. Methods: Data samples from the Gene Expression Omnibus database and protein quantitative trait loci data from genome-wide association studies were integrated to identify overlapping genes. Three machine learning (ML) algorithms were employed to screen core hub genes from these overlapping genes, followed by the construction and external validation of a diagnostic model. Single-cell sequencing data were used to explore the expression profiles of core hub genes across different cell types. Additionally, immune infiltration, functional enrichment, and regulatory networks were analyzed. Finally, the expression trends of the core hub genes were validated in a dextran sulfate sodium (DSS)-induced UC mouse model using RT-qPCR. Results: Mendelian randomization (MR) analysis identified 168 plasma proteins causally associated with UC. Differential expression analysis revealed 1,011 DEGs, and the intersection of DEGs and MR results yielded 12 overlapping genes. Four core hub genes, including EIF5A2, IDO1, CDH5, and MYL5, were identified using three ML algorithms. The nomogram model constructed with these four genes demonstrated strong predictive performance, which was further confirmed in an external validation dataset. GSEA analysis revealed that these genes are involved in various biological processes, including immune response, signal transduction, metabolism, and cellular stress. CIBERSORT immune infiltration analysis showed significant differences in immune cell infiltration between UC and normal tissues. Furthermore, a comprehensive mRNA-miRNA-lncRNA regulatory network was constructed, identifying key molecular interactions potentially driving UC pathogenesis. Single-cell RNA sequencing analysis revealed that CDH5 is primarily expressed in endothelial cells, EIF5A2 is enriched in stem cells/T cells, IDO1 is expressed in monocytes, and MYL5 is found in epithelial and endothelial cells. Finally, RT-qPCR validation in the DSS-induced UC mouse model confirmed that the expression changes of core hub genes were consistent with bioinformatics predictions. Conclusion: This study systematically identified core diagnostic genes and their regulatory networks for UC through multi-omics integration.

Indexed as

diagnostic biomarkersimmune infiltration analysismulti-omics integrationregulatory networkulcerative colitis

Identifiers

PMID41358199
PMCPMC12675271

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.